Hurler Syndrome - 22 Studies Found

Active, not recruiting : Intrathecal Enzyme Replacement for Hurler Syndrome
: Hurler Syndrome
: 2008-03-11
: Drug: IRT Laronidase Laronidase belongs to a class of drug
Completed : Laronidase (Aldurazyme TM) Enzyme Replacement Therapy With Hematopoietic Stem Cell Transplant for Hurler Syndrome
:
  • Mucopolysaccharidosis Type IH
  • MPS I
  • Hurler Syndrome
    : 2010-07-28
    : Drug: Laronidase Laronidase 0.58 mg/kg intravenously (IV) once a week for a maximum of 2 years
Completed : Stem Cell Transplant w/Laronidase for Hurler
:
  • Mucopolysaccharidosis I
  • Hurler Syndrome

: 2005-09-12
:
  • Procedure: Stem Cell Transplant

Completed : Biomarker for Patients With Hurler Disease or High-grade Suspicion for Hurler Disease
:
  • Mucopolysaccharidosis Type I
  • MPS I
  • Hurler-Scheie Syndrome<
    : 2014-10-23
Active, not recruiting : Safety and Dose Ranging Study of Human Insulin Receptor MAb-IDUA Fusion Protein in Adults and Children With MPS I
: Mucopolysaccharidosis I
: 2017-02-09
: Drug: AGT-181 Human Insulin Receptor Monoclonal Antibody-Human alpha-L-iduronidase (HIRMAb-IDUA) Fusion
Completed : Neurobehavioral Phenotypes in MPS III
:
  • Sanfilippo Syndrome Type A
  • Sanfilippo Syndrome Type B
  • : 2013-05-28
Completed : Clinical Study of Aldurazyme in Patients With Mucopolysaccharidosis (MPS) I
:
  • Mucopolysaccharidosis I
  • Hurlers Syndrome
  • Biological: rhIDU (recombinant human-Alpha-L-Iduronidase)

Completed : Stem Cell Transplantation for Hurler
:
  • Mucopolysaccharidosis I
  • Mucopolysaccharidosis VI
  • Mannosido
    : 2005-09-12
    :
    • Procedure: Stem Cell Transplant

Active, not recruiting : Safety and Dose Ranging Study of Insulin Receptor MAb-IDUA Fusion Protein in Patients With MPS I
: Mucopolysaccharidosis I
: 2015-02-19
: Drug: AGT-181 (HIRMAb-IDUA) intravenous infusion over 3-4 hours
Next >>>